NEWS MADE CLEAR

The news, made clear.

Latest news →

Region selects what you read about. NL / EN at the top selects your reading language.

Dutch regulator investigates Biogen over MS drug blood test

AI-generated editorial illustration based on the published article topic; not a documentary photograph.

The Netherlands’ competition regulator is investigating whether Biogen restricted access to a blood test used to assess a serious risk linked to its multiple sclerosis drug Tysabri. The ACM says the arrangement may hinder competitors and affect prices, supply and patient choice.

1 min read—

Recent across sections

Recent news with a spread of topics.

Economy

More →

Regional

More →

General

More →